- Recent Funding
- Investors
- Mission BioCapital
Mission BioCapital portfolio
Mission BioCapital has 13 portfolio companies on record at Recent Funding, with 5 investments in the last 12 months.
About this page
It is a venture capital firm based in San Francisco, US, founded in 2009. It led 2 of the 14 rounds it joined. Its most recent investment on record is Oyster Therapeutics's $60M Series A round in November 2026, alongside Global Brain Corporation, 4BIO Capital, Eli Lilly and 5 others. By category, its portfolio leans toward Health and bio (12) and Robotics and hardware (1). It has co-invested with Pfizer Venture Investments, Eli Lilly and Taiho Ventures, most often Pfizer Venture Investments (4 rounds).
About Mission BioCapital
Funds raised
| Fund | Fund # | Size | Announced |
|---|---|---|---|
| VI | $143.8M | Venture Capital Journal |
What Mission BioCapital invests in
- Health and bio · 12 · 92%
- Robotics and hardware · 1 · 8%
- Commerce and retail · 1 · 8%
Mission BioCapital recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $60M | Global Brain Corporation, 4BIO Capital (lead), Eli Lilly +5 | ||
| round · $350M | Taiho Ventures, General Catalyst, HBM Healthcare Investments +6 | ||
| Series A · $76.65M · lead | Novo Holdings (lead), Catalyze Capital, The Ljungstrom Family Office +5 | ||
| Seed · $33M | 4BIO Capital (lead), AbbVie, BrightEdge - American Cancer Society +3 | ||
| Series A · $41.5M · lead | Lightchain Capital, Cobro Ventures, Sante Ventures (lead) | ||
| Series A · $105M | Novartis Venture Fund (lead), Ono Venture Investment, Bristol-Myers Squibb +6 | ||
| Series B+ · $65M | Taiho Ventures, Jacket River, HBM Healthcare Investments (lead) +6 | ||
| Series B+ · $64M | Eli Lilly, Atlas Venture, Surveyor Capital +4 |
How Mission BioCapital invests
Mission BioCapital portfolio companies
OOyster Therapeutics$60MSeries A · Nov 2026
DDren Bio$350Mround · Oct 2026BBreye Therapeutics$76.65MSeries A · Sep 2026
CCloverleaf Bio$33MSeed · Sep 2026
AAI Proteins$41.5MSeries A · Nov 2025
MMediar Therapeutics$105MSeries A · Mar 2023
AArkuda Therapeutics$64MSeries B+ · Feb 2022
TTune Therapeutics$40MSeries A · Dec 2021
AAsher Bio$108MSeries B+ · Sep 2021
GGlycomine$68MSeries B+ · Jun 2021
WWildtype$13MSeries A · Oct 2019
ZZag Biobacker
JJupiter Bioventuresbacker
| Company | Round with Mission BioCapital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $60M | $60M | Nov 10, 2026 Series A |
Health and bio |
round · $350M | $415M | Oct 29, 2026 round |
Health and bio |
Series A · $76.65M · lead | $80.77M | Sep 29, 2026 Series A |
Health and bio |
Seed · $33M | $33M | Sep 8, 2026 Seed |
Health and bio |
Series A · $41.5M · lead | $59.7M | Nov 18, 2025 Series A |
Health and bio |
Series A · $105M | $181M | Jan 7, 2026 Series B+ |
Health and bio |
Series B+ · $64M | $108M | Feb 10, 2022 Series B+ |
Health and bio |
Series A · $40M | $215M | Jan 12, 2025 Series B+ |
Health and bio |
Series B+ · $108M | $218M | Apr 16, 2024 Series B+ |
Health and bio |
Series B+ · $68M | $195M | May 9, 2025 Series B+ |
Commerce and retail |
Series A · $13M | $117M | Mar 24, 2026 Series B+ |
Health and bio |
backer | undisclosed | — |
Health and bio |
backer | undisclosed | Oct 8, 2025 Series B+ |
Most frequent co-investors
PPfizer Venture Investments4 shared rounds · last Mar 15, 2023
EEli Lilly3 shared rounds · last Nov 10, 2026
TTaiho Ventures3 shared rounds · last Oct 29, 2026
SSR One3 shared rounds · last Oct 29, 2026
HHBM Healthcare Investments3 shared rounds · last Oct 29, 2026
MMass General Brigham Ventures2 shared rounds · last Nov 10, 2026
44BIO Capital2 shared rounds · last Nov 10, 2026
CCormorant Asset Management2 shared rounds · last Oct 29, 2026
NNovo Holdings2 shared rounds · last Sep 29, 2026
BBiotechnology Value Fund2 shared rounds · last Jun 14, 2022
AAtlas Venture2 shared rounds · last Feb 10, 2022
TTekla Capital Management2 shared rounds · last Feb 10, 2022
Similar investors
NNextech Invest13 companies · 4 deals in 12 mo
SSFC Capital13 companies · 4 deals in 12 mo
BBACKED VC13 companies · 3 deals in 12 mo
JJohnson & Johnson Innovation13 companies · 3 deals in 12 mo
- FFidelity Management & Research Company14 companies · 10 deals in 12 mo
Bb2venture14 companies · 7 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Venture funds Mission BioCapital raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.
Share is of the 14 rounds on Recent Funding that name Mission BioCapital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Mission BioCapital, which is a subset of its real portfolio. API: /api/v1/investors/mission-biocapital (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy